Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CEBPA |
| Upstream (Parents) |
|---|
| (<<) FOXC2 → CEBPA |
| (<<) HOXB3 → CEBPA |
| (<<) SOX7 → CEBPA |
| (<<) DLX6 → CEBPA |
| (<<) DMRT2 → CEBPA |
| (<<) NPAS2 → CEBPA |
| (<<) HES1 → CEBPA |
| (<<) TFDP1 → CEBPA |
| (<<) TCFL5 → CEBPA |
| (<<) TSC22D3 → CEBPA |
| (<<) HMGA2 → CEBPA |
| (<<) MSRB2 → CEBPA |
| (<<) SP1 → CEBPA |
| (<<) KLF2 → CEBPA |
| (<<) SLC2A4RG → CEBPA |
| (<<) ZNF281 → CEBPA |
| (<<) GATAD1 → CEBPA |
| (<<) MEF2A → CEBPA |
| (<<) SIX4 → CEBPA |
| (<<) TAF5L → CEBPA |
| (<<) CREBL2 → CEBPA |
| (<<) IRF9 → CEBPA |
| (<<) VAV1 → CEBPA |
| (<<) BATF → CEBPA |
| Downstream (Children) |
|---|
| CEBPA → SOX6 (>>) |
| CEBPA → SIX3 (>>) |
| CEBPA → PAX6 (>>) |
| CEBPA → CTBP1 (>>) |
| CEBPA → NFATC1 (>>) |
| CEBPA → MAFF (>>) |
| CEBPA → PPARG (>>) |
| CEBPA → ALX1 (>>) |
